Aanastra Inc to Present Multiple Posters on RNA Therapeutics at the American Association for Cancer Research (AACR) Annual Meeting 2024
April 03, 2024 06:30 ET
|
Aanastra Inc
Aanastra to present its RNA peptide therapeutics technology at AACR conference
Global Cell and Gene Therapy Markets Report 2024-2028 Featuring Main Players - Mallinckrodt, Vericel, Gilead Sciences, Pharmicell, and Bristol-Myers Squibb
April 03, 2024 03:10 ET
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy Market" report has been added to ResearchAndMarkets.com's offering. The Global Cell and Gene Therapy Market is...
Asia-Pacific Gene Editing Technology Research Report 2024
February 29, 2024 10:03 ET
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Gene Editing Technologies Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.The...
Europe's Gene Editing Technologies Market, Valued at $370 Million in 2023, is Set to Reach $3.26 Billion by 2032 - Country-Specific Insights for Agriculture & Biomedical Applications Unveiled
January 30, 2024 07:50 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Gene Editing Technologies Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.The Europe gene...
Un rapport d’experts détaille les problèmes scientifiques et réglementaires posés par les procédés génétiques de lutte antiparasitaire
November 08, 2023 06:00 ET
|
The Council of Canadian Academies (CCA)
Ottawa (Ontario), Nov. 08, 2023 (GLOBE NEWSWIRE) -- Les procédés d’édition génomique ont des applications prometteuses dans la lutte antiparasitaire, mais posent des problèmes importants en matière...
Expert report details the scientific and regulatory challenges of genetic pest-control technologies
November 08, 2023 06:00 ET
|
The Council of Canadian Academies (CCA)
Ottawa, ON, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Gene-editing technologies hold promising applications for pest control, but pose critical risk-management issues, according to Framing Challenges and...
Verve and Lilly Relationship Expands to Include Verve’s In Vivo Gene Editing Programs Targeting PCSK9 and ANGPTL3
October 31, 2023 06:01 ET
|
Verve Therapeutics
BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Verve Therapeutics, Inc., a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene...
World-Leading Gene Editing Technology Unveiled in United Kingdom
October 23, 2023 12:38 ET
|
Research and Markets
Dublin, Oct. 23, 2023 (GLOBE NEWSWIRE) -- In a momentous stride toward the future of agriculture, scientists have recently achieved a remarkable breakthrough in the realm of gene editing. The...
Gene Editing Market to Be Valued USD 36.4 Billion by 2032, North America in the Lead - Marketresearch.biz Report
October 23, 2023 07:10 ET
|
MarketResearch.biz
New York, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The gene editing market which was valued at USD 7.2 billion in 2022 is expected to witness a CAGR of 18.1%, from 2023 to 2032. It is expected USD 36.4...
US Gene Editing Market Poised for Unprecedented Growth: Rice University's Breakthrough Technology Shines
October 10, 2023 10:08 ET
|
Research and Markets
Dublin, Oct. 10, 2023 (GLOBE NEWSWIRE) -- In the midst of remarkable discoveries in gene editing, researchers at Rice University have unveiled a groundbreaking improvement to traditional CRISPR...